Nov 2 (Reuters) - Emergent Biosolutions Inc
* Emergent Biosolutions reports third quarter and nine months 2017 financial results; raises calendar year 2017 guidance
* Q3 earnings per share $0.68
* Q3 revenue $149.4 million versus I/B/E/S view $124.6 million
* Q3 earnings per share view $0.41 -- Thomson Reuters I/B/E/S
* Emergent Biosolutions Inc sees FY 2017 total revenues $540 million to $560 million
* Emergent Biosolutions Inc sees FY 2017 net income $70 million to $80 million
* Emergent Biosolutions Inc sees FY 2017 adjusted net income $85 million to $95 million Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.